跳至主要内容
临床试验/IRCT20220315054289N1
IRCT20220315054289N1尚未招募3 期

Assessing the effect of Functional Edible Powder Enriched with Probiotics, Curcumin, or Their Combination on Some Inflammatory Markers, Fasting Blood Glucose, and Blood Pressure in Overweight or Obese Individuals with Metabolic Syndrome: a Randomized, double-blind, controlled clinical trial

Shiraz University of Medical Sciences0 个研究点目标入组 128 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • Aged 30 - 65 years
  • Overweight (BMI between 25 to 29.9) or obese (BMI over 30) individuals with metabolic syndrome based on ATP III criteria
  • Not suffering from metabolic, endocrine, or cardiovascular disease (except diabetes, dyslipidemia, and hypertension) at baseline
  • Not suffering from kidney, liver, or systemic diseases at the beginning of the study
  • Not infected with Covid-19 or any other infections for 3 months before the study
  • No history of hospitalization for 3 months prior to the study
  • Has not used antibiotics for 3 months before beginning the study
  • Has not taken curcumin and probiotic supplements, any drugs or supplements for 3 months before the study

排除标准

  • Suffering from components of the metabolic syndrome (diabetes, hypertension, or dyslipidemia) that require drug treatment

研究者

相似试验